Diabetes References

"Diabetes" References

1. Schulze MB, Hu FB. "Primary prevention of diabetes: What can be doneand how much can be prevented?" Annu Rev Public Health. Epub aheadof print, Oct. 26, 2004.

2. Parillo M, Riccardi G. "Diet composition and the risk of type 2diabetes: epidemiological and clinical evidence." Br J Nutr. 92,1:7-19, 2004. www.cabi-publishing.org/journals/bjn

3. Meckling KA, O' Sullivan C, Saari D. "Comparison of a low fat diet toa low carbohydrate diet on weight loss, body composition and risk factors fordiabetes and cardiovascular disease in free-living, overweight men andwomen." J Clin Endocrinol Metab. 89, 6:2717-23, 2004. http://jcem.endojournals.org

4. Gannon MC, Nuttall FQ. "Effect of a high protein, low carbohydratediet on blood glucose control in people with type 2 diabetes." Diabetes.53, 9:2375-82, 2004. http://diabetes.diabetesjournals.org/

5. Gross LS et al. "Increased consumption of refined carbohydrates andthe epidemic of type 2 diabetes in the United States: an ecologicassessment." Am J Clin Nutr. 79, 5:774-9, 2004. www.ajcn.org

6. Schulze MB et al. "Glycemic index, glycemic load and dietary fiberintake and incidence of type 2 diabetes in younger and middle-aged women." AmJ Clin Nutr. 80, 2:348-56, 2004. www.ajcn.org

7. Hodge AM et al. "Glycemic index and dietary fiber and the risk oftype 2 diabetes." Diabetes Care. 27, 11:2701-6, 2004. http://care.diabetesjournals.org

8. Anderson JW et al. "Carbohydrate and fiber recommendations forindividuals with diabetes: a quantitative assessment and meta-analysis of theevidence." J Am Coll Nutr. 23, 1:5-17, 2004. www.am-coll-nutr.org/jacn/jacn.htm

9. Murtaugh MA et al. "Epidemiological support for the protection ofwhole grains against diabetes." Proc Nutr Soc. 62, 1:143-9, 2003. www.cabi-publishing.org/journals/pns

10. Slavin J. "Why whole grains are protective: biologicalmechanisms." Proc Nutr Soc. 62, 1:129-34, 2003. www.cabi-publishing.org/journals/pns

11. Trepel F. "[Dietary fiber: more than a matter of dietetics. II.Application in prevention and therapy.]" Wien Klin Wochenschr. 116,15-16:511-22, 2004.

12. Farnsworth E et al. "Effect of a high-protein, energy-restricteddiet on body composition, glycemic control and lipid concentrations inoverweight and obese hyperinsulinemic men and women." Am J Clin Nutr.78, 1:31-9, 2003. www.ajcn.org

13. Nuttall FQ, Gannon MC. "Metabolic response of people with type 2diabetes to a high protein diet." Nutr Metab (Lond). 1, 1:6, 2004.

14. Belobrajdic DP, McIntosh GH, Owens JA. "A high whey protein dietreduces body weight gain and alters insulin sensitivity relative to red meat inwistar rats." J Nutr. 134, 6:1454-8, 2004. www.nutrition.org

15. Bowen J, Noakes M, Clifton P. "The effect of protein source (dairyvs. mixed) in high protein, energy restricted diets on body composition,vascular health and metabolic markers in overweight adults." Asia Pac JClin Nutr. 12 Suppl:S9, 2003.

16. Jiang R et al. "Nut and peanut butter consumption and risk of type 2diabetes in women." JAMA. 288, 20:2554-60, 2002. www.jama.com

17. Taylor CG, Zahradka P. "Dietary conjugated linoleic acid and insulinsensitivity and resistance in rodent models." Am J Clin Nutr. 79, 6Suppl.:1164S-1168S, 2004. www.ajcn.org

18. Hargrave KM et al. "Conjugated linoleic acid does not improveinsulin tolerance in mice." Obes Res. 11, 9:1104-15, 2003. www.obesityresearch.org

19. Teachey MK et al. "Interactions of conjugated linoleic acid andlipoic acid on insulin action in the obese Zucker rat." Metabolism.52, 9:1167-74, 2003.

20. Eyjolfson V, Spriet LL, Dyck DJ. "Conjugated linoleic acid improvesinsulin sensitivity in young, sedentary humans." Med Sci Sports Exerc.36, 5:814-20, 2004. www.ms-se.com

21. Riserus U et al. "Effects of cis-9, trans-11 conjugated linoleicacid supplementation on insulin sensitivity, lipid peroxidation andproinflammatory markers in obese men." Am J Clin Nutr. 80, 2:279-83,2004. www.ajcn.org

22. Riserus U et al. "Supplementation with trans10cis12-conjugatedlinoleic acid induces hyperproinsulinaemia in obese men: close association withimpaired insulin sensitivity." Diabetologia. 47, 6:1016-9, 2004. http://link.springer.de/link/service/journals/00125/

23. Moloney F et al. "Conjugated linoleic acid supplementation, insulinsensitivity and lipoprotein metabolism in patients with type 2 diabetesmellitus." Am J Clin Nutr. 80, 4:887-95, 2004. www.ajcn.org

24. Planduz S et al. "Plasma antioxidants and type 2 diabetesmellitus." Res Commun Mol Pathol Pharmacol. 109, 5-6:309-18, 2001.

25. Ford ES et al. "The metabolic syndrome and antioxidantconcentrations: findings from the Third National Health and NutritionExamination Survey." Diabetes. 52, 9:2346-52, 2003. http://diabetes.diabetesjournals.org/

26. Montonen J et al. "Dietary antioxidant intake and risk of type 2diabetes." Diabetes Care. 27, 2:362-6, 2004. http://care.diabetesjournals.org

27. Jialal I, Devaraj S, Venugopal SK. "Oxidative stress, inflammationand diabetic vasculopathies: the role of alpha tocopherol therapy." FreeRad Res. 36, 12:1331-6, 2002. www.tandf.co.uk/journals

28. Wan Nazaimoon WM, Khalid BA. "Tocotrienols-rich diet decreasesadvanced glycosylation end-products in non-diabetic rats and improves glycemiccontrol in streptozotocin-induced diabetic rats." Malays J Pathol.24, 2:77-82, 2002.

29. Al Shamsi MS, Amin A, Adeghate E. "Beneficial effect of vitamin E onthe metabolic parameters of diabetic rats." Mol Cell Biochem. 261,1-2:35-42, 2004. www.wkap.nl

30. Mayer-Davis EJ et al. "Plasma and dietary vitamin E in relation toincidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study(IRAS)." Diabetes Care. 25, 12:2172-7, 2002. http://care.diabetesjournals.org

31. Manning PJ et al. "Effect of high-dose vitamin E on insulinresistance and associated parameters in overweight subjects." DiabetesCare. 27, 9:2166-71, 2004. http://care.diabetesjournals.org

32. Halliwell B. "Vitamin E and the treatment and prevention ofdiabetes: a case for a controlled clinical trial." Singapore Med J.43, 9:479-84, 2002.

33. Chew GT, Watts GF. "Coenzyme Q10 and diabetic endotheliopathy:oxidative stress and the 'recoupling hypothesis.'" QJM. 97,8:537-48, 2004.

34. Lamson DW, Plaza SM. "Mitochondrial factors in the pathogenesis ofdiabetes: a hypothesis for treatment." Altern Med Rev. 7, 2:94-111,2002. www.thorne.com/altmedrev

35. Hodgson JM et al. "Coenzyme Q10 improves blood pressure and glycemiccontrol: a controlled trial in subjects with type 2 diabetes." Eur JClin Nutr. 56, 11:1137-42, 2002. www.naturesj.com/ejcn

36. Ceriello A. "New insights on oxidative stress and diabeticcomplications may lead to a 'causal' antioxidant therapy." Diabetes Care.26, 5:1589-96, 2003. http://care.diabetesjournals.org

37. Maritim AC, Sanders RA, Watkins JB 3rd. "Effects of alpha-lipoicacid on biomarkers of oxidative stress in streptozotocin-induced diabeticrats." J Nutr Biochem. 14, 5:288-94, 2003. www.elsevier.com/locate/jnutbio

38. Bitar MS et al. "Alpha-lipoic acid mitigates insulin resistance inGoto-Kakizaki rats." Horm Metab Res. 36, 8:542-9, 2004. www.thieme.com/SID1990079910465/journals/pubid-388413336

39. Packer L, Kraemer K, Rimbach G. "Molecular aspects of lipoic acid inthe prevention of diabetes complications." Nutrition. 17, 10:888-95,2001. www.elsevier.com/locate/nut

40. Melhem MF et al. "Alpha-lipoic acid attenuates hyperglycemia andprevents glomerular mesangial matrix expansion in diabetes." J Am SocNephrol. 13, 1:108-16, 2002. www.jasn.org

41. Ametov AS et al. "The sensory symptoms of diabetic polyneuropathyare improved with alpha-lipoic acid: the SYDNEY trial." Diabetes Care.26, 3:770-6, 2003. http://care.diabetesjournals.org

42. Maritim A et al. "Effects of pycnogenol treatment on oxidativestress in streptozotocin-induced diabetic rats." J Biochem Mol Toxicol.17, 3:193-9, 2003.

43. Liu X et al. "Antidiabetic effect of Pycnogenol French maritime pinebark extract in patients with diabetes type II." Life Sci. 75,21:2505-13, 2004. www.sciencedirect.com/science/journal/00243205

44. Schonlau F, Rohdewald P. "Pycnogenol for diabetic retinopathy. Areview." Int Ophthalmol. 24, 3:161-71, 2001. www.kluweronline.com/issn/0165-5701/current

45. Chausmer AB. "Zinc, insulin and diabetes." J Am Coll Nutr.17, 2:109-15, 1998. www.am-coll-nutr.org/jacn/jacn.htm

46. Roussel AM et al. "Antioxidant effects of zinc supplementation inTunisians with type 2 diabetes mellitus." J Am Coll Nutr. 22,4:316-21, 2003. www.am-coll-nutr.org/jacn/jacn.htm

47. Ayaz M et al. "Protective effect of selenium treatment ondiabetes-induced myocardial structural alterations." Biol Trace Elem Res.89, 3:215-26, 2002. www.humanapress.com

48. Sheng XQ, Huang KX, Xu HB. "New experimental observation on therelationship of selenium and diabetes mellitus." Biol Trace Elem Res.99, 1-3:241-53, 2004. www.humanapress.com

49. Sakurai H. "A new concept: the use of vanadium complexes in thetreatment of diabetes mellitus." Chem Rec. 2, 4:237-48, 2002. www.interscience.wiley.com/jpages/1527-8999

50. Mukherjee B et al. "Vanadium--an element of atypical biologicalsignificance." Toxicol Lett. 150, 2:135-43, 2004. www.sciencedirect.com/science/journal/03784274

51. Barbagello M et al. "Role of magnesium in insulin action, diabetesand cardio-metabolic syndrome X." Mol Aspects Med. 24, 1-3:39-52,2003.

52. Lopez-Ridaura R et al. "Magnesium intake and risk of type 2 diabetesin men and women." Diabetes Care. 27, 1:134-40, 2004. http://care.diabetesjournals.org

53. Song Y et al. "Dietary magnesium intake in relation to plasmainsulin levels and risk of type 2 diabetes in women." Diabetes Care.27, 1:59-65, 2004. http://care.diabetesjournals.org

54. Guerrero-Romero F et al. "Oral magnesium supplementation improvesinsulin sensitivity in non-diabetic subjects with insulin-resistance. A doubleblind, placebo-controlled randomized trial." Diabetes Metab. 30,3:253-8, 2004.

55. Rodriguez-Moran M, Guerrero-Romero F. "Oral magnesiumsupplementation improves insulin sensitivity and metabolic control in type 2diabetic subjects: a randomized double blind controlled trial." DiabetesCare. 26, 4:1147-52, 2003. http://care.diabetesjournals.org

56. Miranda ER, Dey CS. "Effect of chromium and zinc on insulinsignaling in skeletal muscle cells." Biol Trace Elem Res. 101,1:19-36, 2004. www.humanapress.com

57. Ryan GJ et al. "Chromium as adjunctive treatment for type 2diabetes." Ann Pharmacother. 37, 6:876-85, 2003.

58. "A scientific review: the role of chromium in insulinresistance." Diabetes Educ. Suppl:2-14, 2004. www.aadenet.org

59. Juturu V. "Chromium and insulin resistance." ExperimentalBiology 2004, Abstract 351.7.

60. Kim DS, Kim TW, Kang JS. "Chromium picolinate supplementationimproves insulin sensitivity in Goto-Kakizaki diabetic rats." J TraceElem Med Biol. 17, 4:243-7, 2004.

61. Cefalu WT et al. "Oral chromium picolinate improves carbohydrate andlipid metabolism and enhances skeletal muscle Glut-4 translocation in obese,hyperinsulinemic (JCR-LA corpulent) rats." J Nutr. 132, 6:1107-14,2002. www.nutrition.org

62. Shindea UA et al. "Insulin sensitizing action of chromium picolinatein various experimental models of diabetes mellitus." J Trace Elem MedBiol. 18, 1:23-32, 2004.

63. Ghosh D et al. "Role of chromium supplementation in Indians withtype 2 diabetes mellitus." J Nutr Biochem. 13, 11:690-697, 2002. www.elsevier.com/locate/jnutbio

64. Rabinovitz H et al. "Effect of chromium supplementation on bloodglucose and lipid levels in type 2 diabetes mellitus elderly patients." IntJ Vitam Nutr Res. 74, 3:178-82, 2004.

65. Houweling ST et al. "Effects of chromium treatment in patients withpoorly controlled, insulin-treated type 2 diabetes mellitus. A randomized,double blind, placebo-controlled trial." 18th International DiabetesFederation Congress, Aug. 24-29, 2003, Abstract 756.

66. Preuss HG, Bagchi D, Bagchi M. "Protective effects of a novelniacin-bound chromium complex and a grape seed proanthocyanidin extract onadvancing age and various aspects of syndrome X." Ann NY Acad Sci.957:250-9, 2002. www.nyas.org/publications/annals/

67. Preuss HG et al. "Long-term effects of chromium, grape seed extractand zinc on various metabolic parameters of rats." Mol Cell Biochem.223, 1-2:95-102, 2001. www.wkap.nl

68. Yeh GY et al. "Systematic review of herbs and dietary supplementsfor glycemic control in diabetes." Diabetes Care. 26, 4:1277-94,2003. http://care.diabetesjournals.org

69. Saxena A, Vikram NK. "Role of selected Indian plants in managementof type 2 diabetes: a review." J Altern Comp Med. 10, 2:369-78,2004. www.liebertpub.com

70. Porchezhian E, Dobriyal RM. "An overview on the advances of Gymnemasylvestre: chemistry, pharmacology and patents." Pharmazie. 58,1:5-12, 2003.

71. Xie JT et al. "Anti-diabetic effects of Gymnema yunnanenseextract." Pharmacol Res. 47, 4:323-9, 2003.

72. Ananthan R et al. "Effect of Gymnema montanum leaves on serum andtissue lipids in alloxan diabetic rats." Exp Diabesity Res. 4,3:183-9, 2003.

73. Shapiro K, Gong WC. "Natural products used for diabetes." JAm Pharm Assoc (Wash). 42, 2:217-26, 2002.

74. Basch E, Gabardi S, Ulbricht C. "Bitter melon (Momordica charantia):a review of efficacy and safety." Am J Health Syst Pharm. 60,4:356-9, 2003.

75. Jayasooriya AP et al. "Effects of Momordica charantia powder onserum glucose levels and various lipid parameters in rats fed withcholesterol-free and cholesterol-enriched diets." J Ethnopharmacol.72, 1-2:331-6, 2000. www.elsevier.nl/inca/publications/store/5/0/6/0/3/5

76. Chen Q, Chan LL, Li ET. "Bitter melon (Momordica charantia)reduces adiposity, lowers serum insulin and normalizes glucose tolerance in ratsfed a high fat diet." J Nutr. 133, 4:1088-93, 2003. www.nutrition.org

77. Flammang AM et al. "Genotoxicity testing of a fenugreekextract." Food Chem Tox. 42, 11:1769-75, 2004. www.elsevier.nl/locate/foodchemtox

78. Puri D, Prabhu KM, Murthy PS. "Mechanism of action of a hypoglycemicprinciple isolated from fenugreek seeds." Indian J Physiol Pharmacol.46, 4:457-62, 2002.

79. Broca C et al. "Insulinotropic agent ID-1101 (4-hydroxyisoleucine)activates insulin signaling in rat." Am J Physiol Endocrinol Metab.287, 3:E463-71, 2004.

80. Gupta A, Gupta R, Lal B. "Effect of Trigonella foenum-graecum(fenugreek) seeds on glycemic control and insulin resistance in type 2 diabetesmellitus: a double blind placebo-controlled study." J Assoc PhysiciansIndia. 49:1057-61, 2001.

81. Cheng N et al. "Hypoglycemic effects of cinnamon, heshouwu andmushroom extracts in type 2 diabetes mellitus." FASEB J. 16, 4:A647,2002. www.fasebj.org

82. Qin B et al. "Cinnamon extract (traditional herb) potentiates invivo insulin-regulated glucose utilization via enhancing insulin signaling inrats." Diabetes Res Clin Pract. 62, 3:139-48, 2003.

83. Khan A et al. "Cinnamon improves glucose and lipids of people withtype 2 diabetes." Diabetes Care. 26, 12:3215-8, 2003. http://care.diabetesjournals.org

84. Jarvill-Taylor KJ, Anderson RA, Graves DJ. "A hydroxychalconederived from cinnamon functions as a mimetic for insulin in 3T3-L1adipocytes." J Am Coll Nutr. 20, 4:327-36, 2001. www.am-coll-nutr.org/jacn/jacn.htm

85. Anderson RA et al. "Isolation and characterization of polyphenoltype-A polymers from cinnamon with insulin-like biological activity." JAgric Food Chem. 52:65-70, 2004. http://pubs.acs.org/journals/jafcau

86. Liu F et al. "An extract of Lagerstroemia speciosa L. hasinsulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitoryactivities in 3T3-L1 cells." J Nutr. 131, 9:2242-7, 2001. www.nutrition.org

87. Hattori K et al. "Activation of insulin receptors bylagerstroemin." J Pharmacol Sci. 93, 1:69-73, 2003.

88. Judy WV et al. "Antidiabetic activity of a standardized extract(Glucosol) from Lagerstroemia speciosa leaves in Type II diabetics. Adose-dependence study." J Ethnopharmacol. 87, 1:115-7, 2003. www.elsevier.nl/inca/publications/store/5/0/6/0/3/5

89. Waltner-Law ME et al. "Epigallocatechin gallate, a constituent ofgreen tea, represses hepatic glucose production." J Biol Chem. 277,38:34933-40, 2002. www.jbc.org

90. Han MK. "Epigallocatechin gallate, a constituent of green tea,suppresses cytokine-induced pancreatic beta-cell damage." Exp Mol Med.35, 2:136-9, 2003.

91. Wu LY et al. "Effect of green tea supplementation on insulinsensitivity in Sprauge-Dawley rats." J Agric Food Chem. 52, 3:643-8,2004. http://pubs.acs.org/journals/jafcau

92. Wu LY et al. "Green tea supplementation ameliorates insulinresistance and increases glucose transporter IV content in a fructose-fed ratmodel." Eur J Nutr. 43, 2:116-24, 2004. http://link.springer.de/link/service/journals/00394/

93. Tsuneki H et al. "Effect of green tea on blood glucose levels andserum proteomic patterns in diabetic (db/db) mice and on glucose metabolism inhealthy humans." BMC Pharmacol. 4, 1:18, 2004.

94. Rajasekaran S et al. "Hypoglycemic effect of Aloe vera gel onstreptozotocin-induced diabetes in experimental rats." J Med Food.7, 1:61-6, 2004. www.liebertpub.com

95. Can A et al. "Effect of Aloe vera leaf gel and pulp extracts on theliver in type-II diabetic rat models." Biol Pharm Bull. 27, 5:694-8,2004.

96. Bolkent S et al. "Effect of Aloe vera (L.) burm. fil. leaf gel andpulp extracts on kidney in type-II diabetic rat models." Indian J ExpBiol. 42, 1:48-52, 2004.

97. Bates SH, Jones RB, Bailey CJ. "Insulin-like effect ofpinitol." Br J Pharmacol. 130, 8:1944-8, 2000.